Related references
Note: Only part of the references are listed.Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs
Giovanni Filocamo et al.
JOURNAL OF RHEUMATOLOGY (2021)
Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey
Alessandro Tomelleri et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner et al.
GASTROENTEROLOGY (2020)
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Thomas Menter et al.
HISTOPATHOLOGY (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Matthieu Mahevas et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mild or Moderate Covid-19
Rajesh T. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The French response to COVID-19: intrinsic difficulties at the interface of science, public health, and policy
Jean-Paul Moatti
LANCET PUBLIC HEALTH (2020)
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
Carlos Sanchez-Piedra et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020
Alexandre Belot et al.
EUROSURVEILLANCE (2020)
COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes
Rebecca H. Haberman et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Robert Verity et al.
LANCET INFECTIOUS DISEASES (2020)
EFFICACY AND SAFETY OF CANAKINUMAB IN ADULT-ONSET STILL'S DISEASE: A SINGLE-CENTER REAL-LIFE EXPERIENCE
A. Tomelleri et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOPATHY REDUCES SICKNOTES ISSUED BY GPS, DESPITE DELAYS IN DIAGNOSIS: A REAL-LIFE STUDY IN WALES.
E. Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
Alexis Mathian et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
A. Richter et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
A comparison of 12 algorithms for matching on the propensity score
Peter C. Austin
STATISTICS IN MEDICINE (2014)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Share Paper
